These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28339886)

  • 1. Optimal method of measuring the T-peak to T-end interval for risk stratification in primary prevention.
    Rosenthal TM; Masvidal D; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Xue JQ; Morin DP
    Europace; 2018 Apr; 20(4):698-705. PubMed ID: 28339886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
    Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Biering-Sørensen T; Knappe D; Pouleur AC; Claggett B; Wang PJ; Moss AJ; Solomon SD; Kutyifa V
    Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28003221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study.
    Shizuta S; Ando K; Nobuyoshi M; Ikeda T; Yoshino H; Hiramatsu S; Kazatani Y; Yamashiro K; Okajima K; Kajiya T; Kobayashi Y; Kato T; Fujii S; Mitsudo K; Inoue K; Ito H; Haruna Y; Doi T; Nishio Y; Ozasa N; Nishiyama K; Kita T; Morimoto T; Kimura T;
    Clin Res Cardiol; 2012 Feb; 101(2):89-99. PubMed ID: 21960418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Philbert BT; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Sep; 20(FI2):f217-f224. PubMed ID: 29684191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyssynchrony and the risk of ventricular arrhythmias.
    Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive risk stratification for sudden death: signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration.
    Stein KM
    Prog Cardiovasc Dis; 2008; 51(2):106-17. PubMed ID: 18774010
    [No Abstract]   [Full Text] [Related]  

  • 10. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction.
    Morin DP; Saad MN; Shams OF; Owen JS; Xue JQ; Abi-Samra FM; Khatib S; Nelson-Twakor OS; Milani RV
    Europace; 2012 Aug; 14(8):1172-9. PubMed ID: 22277646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
    Bozyel S; Aktas M; Mutluer FO; Guler TE; Dervis E; Argan O; Celikyurt U; Agir A; Vural A
    Acta Cardiol; 2019 Jun; 74(3):246-251. PubMed ID: 30058473
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tpeak-Tend interval during therapeutic hypothermia can predict upcoming ventricular fibrillation in subjects with aborted arrhythmic sudden cardiac death: 3-years follow-up results.
    Yoon N; Hong S; Glass A; Kim SS; Kim MC; Cho JY; Lee KH; Sim DS; Yoon HJ; Kim KH; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong M; Park JC; Cho JG
    Europace; 2017 Dec; 19(suppl_4):iv17-iv24. PubMed ID: 29220423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing risks of monomorphic vs. non-monomorphic ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study.
    Tereshchenko LG; Waks JW; Tompkins C; Rogers AJ; Ehdaie A; Henrikson CA; Dalouk K; Raitt M; Kewalramani S; Kattan MW; Santangeli P; Wilkoff BW; Kapadia SR; Narayan SM; Chugh SS
    Europace; 2024 Jun; 26(6):. PubMed ID: 38703375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-wave alternans, restitution of human action potential duration, and outcome.
    Narayan SM; Franz MR; Lalani G; Kim J; Sastry A
    J Am Coll Cardiol; 2007 Dec; 50(25):2385-92. PubMed ID: 18154963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
    Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LV mechanical dispersion as a predictor of ventricular arrhythmia in patients with advanced systolic heart failure : A pilot study.
    Banasik G; Segiet O; Elwart M; Szulik M; Lenarczyk R; Kalarus Z; Kukulski T
    Herz; 2016 Nov; 41(7):599-604. PubMed ID: 26883898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.